Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysisChanghoon Yoo, Song Cheol Kim, Ki Byung Song et al.|British Journal of Cancer|2020Cited by 38